Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Payne

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Medical Genetics. Part A|December 21, 2013
Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year studyJonathan M Payne, Tania Pickering, Melanie Porter, et al.
Neuropsychology|March 21, 2017
Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1Amelia K Lewis, Melanie A Porter, Tracey A Williams, et al.
Stem Cell Research|October 22, 2020
Generation of four iPSC lines from Neurofibromatosis Type 1 patientsKiymet Bozaoglu, Wei Shern Lee, Kristina M Haebich, et al.
Journal of Autism and Developmental Disorders|March 6, 2023
Delineating Visual Habituation Profiles in Preschoolers with Neurofibromatosis Type 1 and Autism Spectrum Disorder: A Cross-Syndrome StudyDarren R Hocking, Xiaoyun Sun, Kristina Haebich, et al.
Neuropsychological Rehabilitation|August 5, 2023
The decision-making task: Development and evaluation in a paediatric traumatic brain injury populationNikita Tuli Sood, Celia Godfrey, Sarah Youn, et al.
Developmental Medicine and Child Neurology|September 5, 2025
Socially oriented attention in young children with neurofibromatosis type 1: An eye-tracking studyKristina M Haebich, Darren R Hocking, Hayley Darke, et al.
Annals of Clinical and Translational Neurology|February 6, 2020
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1Nicole J Ullrich, Jonathan M Payne, Karin S Walsh, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|April 11, 2023
Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1Alice Maier, Natalie A Pride, Stephen J C Hearps, et al.
British Journal of Clinical Pharmacology|June 2, 2020
A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disabilityDaryl Efron, Jeremy L Freeman, Noel Cranswick, et al.
BMJ Open|March 11, 2020
Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trialDaryl Efron, Kaitlyn Taylor, Jonathan M Payne, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Medical Genetics. Part A|December 21, 2013
Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year studyJonathan M Payne, Tania Pickering, Melanie Porter, et al.
Neuropsychology|March 21, 2017
Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1Amelia K Lewis, Melanie A Porter, Tracey A Williams, et al.
Stem Cell Research|October 22, 2020
Generation of four iPSC lines from Neurofibromatosis Type 1 patientsKiymet Bozaoglu, Wei Shern Lee, Kristina M Haebich, et al.
Journal of Autism and Developmental Disorders|March 6, 2023
Delineating Visual Habituation Profiles in Preschoolers with Neurofibromatosis Type 1 and Autism Spectrum Disorder: A Cross-Syndrome StudyDarren R Hocking, Xiaoyun Sun, Kristina Haebich, et al.
Neuropsychological Rehabilitation|August 5, 2023
The decision-making task: Development and evaluation in a paediatric traumatic brain injury populationNikita Tuli Sood, Celia Godfrey, Sarah Youn, et al.
Developmental Medicine and Child Neurology|September 5, 2025
Socially oriented attention in young children with neurofibromatosis type 1: An eye-tracking studyKristina M Haebich, Darren R Hocking, Hayley Darke, et al.
Annals of Clinical and Translational Neurology|February 6, 2020
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1Nicole J Ullrich, Jonathan M Payne, Karin S Walsh, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|April 11, 2023
Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1Alice Maier, Natalie A Pride, Stephen J C Hearps, et al.
British Journal of Clinical Pharmacology|June 2, 2020
A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disabilityDaryl Efron, Jeremy L Freeman, Noel Cranswick, et al.
BMJ Open|March 11, 2020
Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trialDaryl Efron, Kaitlyn Taylor, Jonathan M Payne, et al.
Pageof 9